D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overview All 13F holders of CRVS Full Q2 2026 holdings

Shares (Q2 2026): 133,177
Value: $1.99M
% of portfolio: <0.1%
Quarters held: 3; Since Q3 2025

Holdings of CRVS by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	133,177	$1.99M	<0.1%	+133,177	New	Holders
Q1 2026	0	$0	0.0%	−64,915−100.0%	Sold out	Holders
Q4 2025	64,915	$499.8K	<0.1%	+39,340+153.8%	Added	Holders
Q3 2025	25,575	$188.5K	<0.1%	+25,575	New	Holders